Harvard Bioscience Gross Margin 2010-2023 | HBIO

Current and historical gross margin for Harvard Bioscience (HBIO) over the last 10 years. The current gross profit margin for Harvard Bioscience as of December 31, 2023 is %.
Harvard Bioscience Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2023-12-31 $0.11B $0.07B 58.93%
2023-09-30 $0.11B $0.07B 58.93%
2023-06-30 $0.11B $0.06B 55.26%
2023-03-31 $0.11B $0.06B 55.26%
2022-12-31 $0.11B $0.06B 53.98%
2022-09-30 $0.12B $0.07B 55.08%
2022-06-30 $0.12B $0.07B 57.02%
2022-03-31 $0.12B $0.07B 56.20%
2021-12-31 $0.12B $0.07B 56.30%
2021-09-30 $0.12B $0.07B 55.56%
2021-06-30 $0.11B $0.06B 55.86%
2021-03-31 $0.11B $0.06B 57.14%
2020-12-31 $0.10B $0.06B 56.86%
2020-09-30 $0.10B $0.06B 55.88%
2020-06-30 $0.11B $0.06B 56.19%
2020-03-31 $0.11B $0.06B 54.46%
2019-12-31 $0.12B $0.06B 55.17%
2019-09-30 $0.12B $0.07B 55.46%
2019-06-30 $0.12B $0.07B 55.37%
2019-03-31 $0.12B $0.07B 53.66%
2018-12-31 $0.12B $0.06B 51.64%
2018-09-30 $0.11B $0.06B 50.00%
2018-06-30 $0.10B $0.05B 49.00%
2018-03-31 $0.09B $0.04B 49.43%
2017-12-31 $0.08B $0.04B 51.28%
2017-09-30 $0.08B $0.04B 50.00%
2017-06-30 $0.09B $0.04B 48.86%
2017-03-31 $0.10B $0.05B 48.42%
2016-12-31 $0.10B $0.05B 47.12%
2016-09-30 $0.11B $0.05B 47.17%
2016-06-30 $0.11B $0.05B 46.73%
2016-03-31 $0.11B $0.05B 46.36%
2015-12-31 $0.11B $0.05B 44.95%
2015-09-30 $0.11B $0.05B 45.05%
2015-06-30 $0.11B $0.05B 44.55%
2015-03-31 $0.11B $0.05B 44.44%
2014-12-31 $0.11B $0.05B 45.37%
2014-09-30 $0.11B $0.05B 44.34%
2014-06-30 $0.11B $0.05B 44.34%
2014-03-31 $0.11B $0.05B 44.76%
2013-12-31 $0.11B $0.05B 44.76%
2013-09-30 $0.11B $0.05B 45.71%
2013-06-30 $0.11B $0.05B 46.23%
2013-03-31 $0.11B $0.05B 47.22%
2012-12-31 $0.11B $0.05B 47.27%
2012-09-30 $0.11B $0.05B 46.85%
2012-06-30 $0.11B $0.05B 46.85%
2012-03-31 $0.11B $0.05B 46.36%
2011-12-31 $0.11B $0.05B 46.30%
2011-09-30 $0.11B $0.05B 46.79%
2011-06-30 $0.11B $0.05B 47.71%
2011-03-31 $0.11B $0.05B 47.22%
2010-12-31 $0.11B $0.05B 48.15%
2010-09-30 $0.11B $0.05B 48.11%
2010-06-30 $0.10B $0.05B 47.52%
2010-03-31 $0.09B $0.05B 48.39%
2009-12-31 $0.09B $0.04B 47.67%
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.157B $0.112B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Mettler-Toledo (MTD) United States $26.480B 32.51
Bruker (BRKR) United States $11.768B 31.38
Kewaunee Scientific (KEQU) United States $0.099B 11.71